Estradiol targets T cell signaling pathways in human systemic lupus

Clinical Immunology

Volumn 133, Issue 3, 2009, Pages 428-436

  Walters, Emily ^a   Rider, Virginia ^a   Abdou, Nabih I ^b   Greenwell, Cindy ^b   Svojanovsky, Stan ^c   Smith, Peter ^c   Kimler, Bruce F ^d  

^a PITTSBURG STATE UNIVERSITY   (United States)

^b Center for Rheumatic Disease   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Estradiol; Interferon ; Microarray; SLE; T cell signaling

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; DRIP 150 PROTEIN; ESTRADIOL; HYDROXYCHLOROQUINE; IFIT1 PROTEIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ACTIVITY; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; MEASUREMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SAMPLE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ADULT; CARRIER PROTEINS; ESTRADIOL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEDIATOR COMPLEX; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; YOUNG ADULT;

EID: 70350610653     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.09.002     Document Type: Article

References (57)

1. Boumpas D.T., Fessler B.J., Austin III H.A., Balow J.E., Klippel J.H., and Lockshin M.D. Systemic lupus erythematosus: emerging concepts. Part 2: dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann. Intern. Med. 123 (1995) 42-53
2. Zhang J., Jacobi A.M., Wang T., Berlin R., Volpe B.T., and Diamond B. Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J. Autoimmun. (2009) doi:10.1016/j.jaut.2009.03.011
3. Tenbrock K., Juang Y.T., Kyttaris V.C., and Tsokos G.C. Altered signal transduction in SLE T cells. Rheumatology 46 (2007) 1525-1530
4. Kyttaris V.C., Krishnan S., and Tsokos G.C. Systems biology in systemic lupus erythematosus: integrating genes, biology and immune function. Autoimmunity 39 (2006) 705-709
5. Cervera R., Khamashta M.A., Font J., Sebastiani G.D., Gil A., Lavilla P., et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 72 (1993) 113-124
6. Rider V., and Abdou N.I. Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int. Immunopharmacol. 1 (2001) 1009-1024
7. Rider V., Li X., and Abdou N.I. Hormonal influences in the expression of systemic lupus erythematosus. In: Tsokos G.C., Gordon P.C., and Smolen J.S. (Eds). Systemic Lupus Erythematosus: A Companion to Rheumatology Elsevier, New York, NY (2007) 87-94
8. Cohen-Solal J.F., Jeganathan V., Grimaldi C.M., Peeva E., and Diamond B. Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr. Top. Microbiol. Immunol. 305 (2006) 67-88
9. Khorasanizadeh S., and Rastinejad F. Nuclear-receptor interactions on DNA-response elements. Trends Biochem. Sci. 26 (2001) 384-390
10. O'Malley B.W. Coregulators: from whence came these "master genes". Mol. Endocrinol. 21 (2007) 1009-1013
11. Wolf I.M., Heitzer M.D., Grubisha M., and DeFranco D.B. Coactivators and nuclear receptor transactivation. J. Cell. Biochem. 104 (2008) 1580-1586
12. Ordentlich P., Downes M., and Evans R.M. Corepressors and nuclear hormone receptor function. Curr. Top. Microbiol. Immunol. 254 (2001) 101-116
13. Burakov D., Crofts L.A., Chang C.P., and Freedman L.P. Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor. J. Biol. Chem. 277 (2002) 14359-14362
14. Chiba N., Suldan Z., Freedman L.P., and Parvin J.D. Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme. J. Biol. Chem. 275 (2000) 10719-10722
15. Ohashi P.S. T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat. Rev., Immunol. 2 (2002) 427-438
16. Bauer J.W., Baechler E.C., Petri M., Batliwalla F.M., Crawford D., Ortmann W.A., et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med. 3 (2006) 2274-2284
17. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2610-2615
18. Crow M.K., Kirou K.A., and Wohlgemuth J. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36 (2003) 481-490
19. Crow M.K., and Kirou K.A. Interferon-alpha in systemic lupus erythematosus. Curr. Opin. Rheumatol. 16 (2004) 541-547
20. Kozyrev S.V., and Alarcon-Riquelme M.E. The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 40 (2007) 591-601
21. Kariuki S.N., Kirou K.A., MacDermott E.J., Barillas-Arias L., Crow M.K., and Niewold T.B. Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J. Immunol. 182 (2009) 34-38
22. Baechler E.C., Batliwalla F.M., Reed A.M., Peterson E.J., Gaffney P.M., Moser K.L., Gregersen P.K., and Behrens T.W. Gene expression profiling in human autoimmunity. Immunol.Rev. 210 (2006) 120-137
23. Abdou N.I., Rider V., Greenwell C., Li X., and Kimler B.F. Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. Clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial. J. Rheumatol. 35 (2008) 797-803
24. Rider V., Foster R.T., Evans M., Suenaga R., and Abdou N.I. Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 89 (1998) 71-80
25. Rider V., Jones S., Evans M., Bassiri H., Afsar Z., and Abdou N.I. Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J. Rheumatol. 28 (2001) 2644-2649
26. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25 (1982) 1271-1277
27. Crow M.K. Interferon pathway activation in systemic lupus erythematosus. Curr. Rheumatol. Rep. 7 (2005) 463-468
28. Ye S., Pang H., Gu Y., Hua J., Chen X.G., Bao C.D., et al. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1. Rheumatology 42 (2003) 1155-1163
29. Lee J., and Safe S. Coactivation of estrogen receptor alpha (ER alpha)/Sp1 by vitamin D receptor interacting protein 150 (DRIP150). Arch. Biochem. Biophys. 461 (2007) 200-210
30. Kane L.P., and Weiss A. The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol. Rev. 192 (2003) 7-20
31. Zikherman J., and Weiss A. Antigen receptor signaling in the rheumatic diseases. Arthritis Res. Ther. 11 (2009) 202 10.1186/ar2528
32. Shi Y., Liu C.H., Roberts A.I., Das J., Xu G., Ren G., et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know. Cell Res. 16 (2006) 126-133
33. Rincón M., and Davis R.J. Regulation of the immune response by stress-activated protein kinases. Immunol. Rev. 228 (2009) 212-224
34. Fernandez D., Bonilla E., Mirz N., Niladn B., and Perl A. Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum. 54 (2006) 2983-2988
35. Feske S. Calcium signaling in lymphocyte activation and disease. Nature 7 (2007) 690-702
36. Tsokos G.C. Calcium signaling in systemic lupus erythematosus lymphocytes and its therapeutic exploitation. Arthritis Rheum. 58 (2008) 1216-1219
37. Nagy G., Koncz A., Fernandez D., and Perl A. Nitric oxide, mitochondrial hyperpolarization and T-cell activation. Free Radic. Biol. Med. (2007) 1625-1631
38. Fernandez D., and Perl A. Metabolic control of T cell activation and death in SLE. Auotimmunity Rev. (2009) 184-189
39. Perl A., Gergely Jr. P., Koncz A., and Banki K. Mitochondrial hyperpolarization: a checkpoint of T cell life, death, and autoimmunity. Trends Immunol. 25 (2004) 360-367
40. Crispín J.C., and Tsokos G.C. Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmunity Rev. 8 (2009) 190-195
41. Gómez-Martín D., Díaz-Zamudio M., Crispín J.C., and Alcocer-Varela J. Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities. Autoimmun. Rev. 9 (2009) 34-39
42. Ibiza S., Víctor V.M., Boscá I., Ortega A., Urzainqui A., O'Connor J.E., et al. Endothelial nitric oxide synthase regulates T cell receptor signaling at the immunological synapse. Immunity 24 (2006) 753-765
43. Katsiari C.G., Vasileios V.C., Juang Y.-T., and Tsokos G.C. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J. Clin. Invest 115 (2005) 3193-3204
44. Kammer G.M. Deficient protein kinase a in systemic lupus erythematosus: a disorder of T lymphocyte signal transduction. Ann. NY Acad. Sci. 968 (2002) 96-105
45. Zikherman J., and Weiss A. Antigen receptor signaling in the rheumatic diseases. Arthritis Res. Ther. 11 (2009) 202 10.1186/ar2528
46. Gorjestani S., Rider V., Kimler B.F., Greenwell C., and Abdou N.I. Extracellular signal-regulated kinase 1/2 signalling in SLE T cells is influenced by oestrogen and disease activity. Lupus 17 (2008) 548-554
47. Sawalha A.H., Jeffries M., Webb R., Lu Q., Gorelik G., Ray D., et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun. 9 (2008) 368-378
48. Singh R.R. IL-4 and many roads to lupus like autoimmunity. Clin. Immunol. 108 (2003) 73-79
49. Brown K.D., Claudio E., and Siebenlist U. The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res. Ther. 10 (2008) 212 10.1186/ar2457
50. Maniati E., Potter P., Rogers N.J., and Morley B.J. Control of apoptosis in autoimmunity. J. Pathol. 214 (2008) 190-198
51. Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 28 (2007) 521-574
52. Kirou K.A., Lee C., George S., Louca K., Papagiannis I.G., Peterson M.G., et al. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 50 (2004) 3958-3967
53. Kirou K.A., Lee C., George S., Louca K., Peterson M.G., and Crow M.K. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 52 (2005) 1491-1503
54. Lau J.F., Nusinzon I., Burakov D., Freedman L.P., and Horvath C.M. Role of metazoan mediator proteins in interferon-responsive transcription. Mol. Cell Biol. 23 (2003) 620-628
55. Chadick J.Z., and Asturias F.J. Structure of eukaryotic Mediator complexes. Trends Biochem. Sci. 30 (2005) 264-271
56. Wärnmark A., Almlöf T., Leers J., Gustafsson J.A., and Treuter E. Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERalpha and ERbeta. J. Biol. Chem. 276 (2001) 23397-23404
57. Rider V., Li X., Peterson G., Dawson J., Kimler B.F., and Abdou N.I. Differential expression of estrogen receptors in women with systemic lupus erythematosus. J. Rheumatol. 33 (2006) 1093-1101